Surrogate Augmented Deep Predictive Learning for Retinopathy of Prematurity
Surrogate Augmented Deep Predictive Learning for Retinopathy of Prematurity
批准号:
10740289
负责人:
Yong Chen
金额:
$48.21万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-30 至 2025-09-29
关键词:
AddressAgeAge FactorsAlgorithmsBirth WeightBlindnessCaringChildhoodClinicalDataData SetData SourcesDemographic FactorsDetectionDevelopmentDiagnosticDiseaseEarly DiagnosisEarly identificationEvaluationEventEyeFundingFutureGestational AgeGoalsHealthcareImageImage AnalysisInfantInfant CareLearningLongitudinal, observational studyMachine LearningMedicalMethodsNorth AmericaOphthalmologistOphthalmologyPerformancePremature InfantPreventionProspective StudiesQuality of CareReaderReproducibilityResearchResourcesRetinaRetinopathy of PrematurityRiskRisk FactorsScheduleStatistical MethodsSurvival RateTechniquesTimeTrainingUnited StatesValidationclinical practicedeep learningexperiencefollow-uphigh risk infantimprovedinnovationlearning algorithmmachine learning algorithmnovelophthalmic examinationportabilityprediction algorithmpreventretinal imagingrisk stratificationserial imagingskillstool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Surrogate Augmented Deep Predictive Learning
for Retinopathy of Prematurity
ABSTRACT
This proposal aims to develop novel surrogate augmented deep predictive learning algorithms for predicting
retinopathy of prematurity (ROP). The proposal directly addresses a critical clinical burden in ophthalmology that
limited ROP experts are available in the United States and worldwide, yet the early detection of ROP for timely
treatment has tremendous clinical benefit for infants in preventing childhood blindness. Using a unique and
massive dataset with 7905 image sets collected from a longitudinal observational study of 1257 premature
infants from 13 centers in North America, we plan to develop, validate, and evaluate novel analytic algorithms
that hold a promise of directly improving clinical practice in the ROP care of premature infants.
The overarching goals of this proposal are: (1) to develop novel methods for performing risk stratification through
the surrogate augmented deep predictive learning of earliest retinal images (prior to 34 weeks postmenstrual
age [PMA]) and the most important ROP risk factors (birth weight, gestational age) for early prediction of
referral-warranted ROP (RW-ROP), defined as plus disease, ROP in zone I, or stage 3 ROP or greater; and (2)
to optimize the ROP schedule through the surrogate augmented deep predictive learning of accumulated
longitudinal retinal images for the dynamic prediction of RW-ROP. Our methods, after proper validation in
future prospective studies, may serve as a useful tool for ROP risk stratification and optimization of scheduling
of ROP examinations, which can reduce the burden of ROP examination for both infants and ophthalmologists
while improving the eye care of premature infants for the prevention of childhood blindness.
The Specific Aims to achieve these goals are:
Aim #1: Develop and evaluate the surrogate augmented deep predictive learning of the earliest retinal
image sets taken prior to 34 weeks PMA and demographic factors to predict RW-ROP. Accurate risk
stratification through earlier prediction of RW-ROP will help identify high-risk infants for close follow-up by
ophthalmologists for early detection and timely treatment of ROP, and low risk infants who are currently receiving
unnecessary physically stressful retinal examinations for less frequent ROP examinations.
Aim #2: Implement the surrogate augmented deep predictive learning of accumulated retinal images
over time to dynamically predict RW-ROP. The dynamic prediction of the future course of ROP by deep
learning of longitudinally accumulated retinal images will help optimize the schedule of ROP examinations by
ophthalmologists, thus reduce the burden of ROP examinations for both infants and ophthalmologists.
The successful completion of this project will lead to novel analytic algorithms of retinal images for early
identification of high-risk infants for close follow-up and for optimization of ROP exam schedule, which will lead
to earlier detection and timely treatment of ROP while minimizing the number of ROP exams. This research is
highly feasible and potentially transformative in its global impact on the ROP care of premature infants.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ClinEX - Clinical Evidence Extraction, Representation, and Appraisal
-
批准号:10754029
-
项目类别:
-
资助金额:$70.88万
-
财政年份:2023
-
负责人:Yong Chen
-
依托单位:
Development of Magnetic Resonance Fingerprinting (MRF) to Assess Response to Neoadjuvant Chemotherapy in Breast Cancer
-
批准号:10713097
-
项目类别:
-
资助金额:$56.39万
-
财政年份:2023
-
负责人:Yong Chen
-
依托单位:
Development of Magnetic Resonance Fingerprinting in Kidney for Evaluation of Renal Cell Carcinoma
-
批准号:10522570
-
项目类别:
-
资助金额:$46.47万
-
财政年份:2022
-
负责人:Yong Chen
-
依托单位:
Development of Magnetic Resonance Fingerprinting in Kidney for Evaluation of Renal Cell Carcinoma
-
批准号:10707150
-
项目类别:
-
资助金额:$51.61万
-
财政年份:2022
-
负责人:Yong Chen
-
依托单位:
PheBC: bias correction methods for EHR derived phenotype
-
批准号:10839649
-
项目类别:
-
资助金额:$24.77万
-
财政年份:2021
-
负责人:Yong Chen
-
依托单位:
PheBC: bias correction methods for EHR derived phenotype
-
批准号:10471166
-
项目类别:
-
资助金额:$34.2万
-
财政年份:2021
-
负责人:Yong Chen
-
依托单位:
CICADA: clinical informatics and computational approaches for drug-repositioning of AD/ADRD
-
批准号:10476677
-
项目类别:
-
资助金额:$79.4万
-
财政年份:2021
-
负责人:Yong Chen
-
依托单位:
TRiPOD: Toward Reusable Phenotypes in Observational Data for AD/ADRD - managing definitions and correcting bias
-
批准号:10642888
-
项目类别:
-
资助金额:$78.43万
-
财政年份:2021
-
负责人:Yong Chen
-
依托单位:
TRiPOD: Toward Reusable Phenotypes in Observational Data for AD/ADRD - managing definitions and correcting bias
-
批准号:10279554
-
项目类别:
-
资助金额:$81.17万
-
财政年份:2021
-
负责人:Yong Chen
-
依托单位:
CICADA: clinical informatics and computational approaches for drug-repositioning of AD/ADRD
-
批准号:10490346
-
项目类别:
-
资助金额:$75.43万
-
财政年份:2021
-
负责人:Yong Chen
-
依托单位:
PheBC: bias correction methods for EHR derived phenotype
-
批准号:10624825
-
项目类别:
-
资助金额:$34.22万
-
财政年份:2021
-
负责人:Yong Chen
-
依托单位:
Academic-Industry Partnership for the Translation of a 4D in vivo Dosimetry Approach for Radiation Therapy
-
批准号:10462762
-
项目类别:
-
资助金额:$40.44万
-
财政年份:2019
-
负责人:Yong Chen
-
依托单位:
Academic-Industry Partnership for the Translation of a 4D in vivo Dosimetry Approach for Radiation Therapy
-
批准号:9912379
-
项目类别:
-
资助金额:$45.28万
-
财政年份:2019
-
负责人:Yong Chen
-
依托单位:
Academic-Industry Partnership for the Translation of a 4D in vivo Dosimetry Approach for Radiation Therapy
-
批准号:10251644
-
项目类别:
-
资助金额:$48.49万
-
财政年份:2019
-
负责人:Yong Chen
-
依托单位:
Academic-Industry Partnership for the Translation of a 4D in vivo Dosimetry Approach for Radiation Therapy
-
批准号:10705086
-
项目类别:
-
资助金额:$39.26万
-
财政年份:2019
-
负责人:Yong Chen
-
依托单位:
Academic-Industry Partnership for the Translation of a 4D in vivo Dosimetry Approach for Radiation Therapy
-
批准号:10260605
-
项目类别:
-
资助金额:$39.28万
-
财政年份:2019
-
负责人:Yong Chen
-
依托单位:
Modeling temporomandibular joint disorders pain: role of transient receptor potential ion channels
-
批准号:9595624
-
项目类别:
-
资助金额:$37.72万
-
财政年份:2018
-
负责人:Yong Chen
-
依托单位:
Modeling temporomandibular joint disorders pain: role of transient receptor potential ion channels
-
批准号:9769689
-
项目类别:
-
资助金额:$38.24万
-
财政年份:2018
-
负责人:Yong Chen
-
依托单位:
Modeling temporomandibular joint disorders pain: role of transient receptor potential ion channels
-
批准号:10440366
-
项目类别:
-
资助金额:$37.86万
-
财政年份:2018
-
负责人:Yong Chen
-
依托单位:
Sexual dimorphism of neuroimmune interactions in temporomandibular joint disorders pain: contribution of a newly identified female-specific pain signaling axis IL23/IL17A/TRPV1
-
批准号:10596384
-
项目类别:
-
资助金额:$12.8万
-
财政年份:2018
-
负责人:Yong Chen
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: